Harmony Biosciences Holdings

Harmony Biosciences Announces Promising Results from Phase 2 Study on Pitolisant for Myotonic Dystrophy Type 1

PLYMOUTH MEETING, PA — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) has recently unveiled positive topline results from its Phase 2 signal detection study. The study evaluated the safety and efficacy …

Harmony Biosciences Announces Promising Results from Phase 2 Study on Pitolisant for Myotonic Dystrophy Type 1 Read More
Patriot Growth Insurance Services

Patriot Growth Insurance Services Expands New England Footprint with Blueprint Benefit Advisors Partnership

FORT WASHINGTON, PA — Patriot Growth Insurance Services, LLC has announced a strategic partnership with Blueprint Benefit Advisors. This move marks a significant expansion of Patriot’s rapidly growing presence in …

Patriot Growth Insurance Services Expands New England Footprint with Blueprint Benefit Advisors Partnership Read More